Samsara BioCapital, L.P. - Nov 18, 2024 Form SCHEDULE 13D/A Schedule Report for Syros Pharmaceuticals, Inc. (SYRS)

Filing Manager
Samsara BioCapital, L.P.
Reporting Manager
Samsara BioCapital, L.P.
Security
Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share
Symbol
SYRS
Shares outstanding
27.2M shares
Disclosed Ownership
707K shares
Ownership
2.6%
Form type
SCHEDULE 13D/A
Date filed
3/27/2025, 06:17 PM
Date of event
Nov 18, 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Samsara BioCapital, L.P. 2.6% 707K 0 707K /s/ Srinivas Akkaraju By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member 0001699737
Samsara BioCapital GP, LLC 2.6% 707K 0 707K /s/ Srinivas Akkaraju By Srinivas Akkaraju, Managing Member 0001888829
Srinivas Akkaraju 2.6% 707K 0 707K /s/ Srinivas Akkaraju Srinivas Akkaraju 0001253170